Summary of Purpose
This study is randomized, open-lable, parallel-group and comparator-controlled. 456 consecutive patients with acute ischemic stroke admitted within the first 72 hours after onset of symptoms will be studied. Those patients who will be randomly assigned to receive 2 different treatment for the first 3 days of hospitalization(non-statin-therapy group) or to immediately receive rosuvastatin orally at a dose of 20mg...Read More →
The following dates are available for this trial. Trial information last updated on 24 June 2015.
|1 Sep 2015||17 Jun 2015||1 Sep 2017||1 Sep 2018||1 Jun 2015||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Sponsors See All
- Allocation: Randomized
- Masking: Open Label
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Chun-Feng Liu, Ph.D,M.D.